Tanshinones inhibit the growth of breast cancer cells through epigenetic modification of Aurora A expression and

Related Experiment Video

Updated: May 23, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Yi Gong1, Yanli Li, Hamid M Abdolmaleky

  • 1Nutrition/Metabolism Laboratory, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.

Plos One
|April 10, 2012
PubMed

Insights

Tanshinones from Salvia Miltiorrhiza inhibit breast cancer cell growth, particularly tanshinone I (T1). T1 targets Aurora A, a protein overexpressed in tumors, offering a potential new breast cancer therapy with minimal side effects.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Breast cancer remains a leading cause of cancer-related mortality worldwide.
  • Novel therapeutic agents with improved efficacy and safety profiles are urgently needed.
  • Salvia Miltiorrhiza and its active compounds, tanshinones, have shown potential in traditional medicine and preliminary studies.

Purpose of the Study:

  • To evaluate the anti-cancer effects of tanshinones on breast cancer cells in vitro.
  • To elucidate the cellular and molecular mechanisms underlying tanshinone-induced growth inhibition and apoptosis.
  • To investigate the role of Aurora A kinase as a potential therapeutic target.

Main Methods:

  • In vitro cell culture of estrogen-dependent and -independent breast cancer cell lines, including triple-negative MDA-MB231.
  • Dose-response assays to determine growth inhibition.
  • Cell cycle analysis and apoptosis assays (Western blotting for c-PARP, survivin, Aurora A).
  • siRNA-mediated knockdown of Aurora A.
  • Epigenetic analysis (DNA methylation and histone acetylation assays).

Main Results:

  • Tanshinones exhibited dose-dependent inhibition of breast cancer cell growth, with tanshinone I (T1) being the most potent.
  • T1 effectively inhibited triple-negative breast cancer cells and induced cell cycle arrest and apoptosis.
  • T1's anti-growth activity was strongly correlated with the downregulation of Aurora A, a validated target.
  • T1 treatment reduced histone H3 acetylation at the Aurora A gene, suggesting epigenetic regulation.
  • Tanshinones demonstrated minimal adverse effects on normal mammary epithelial cells.

Conclusions:

  • Tanshinone I (T1) possesses potent in vitro activity against breast cancer cells, including triple-negative subtypes.
  • Downregulation of Aurora A kinase is a key mechanism mediating T1's anti-cancer effects.
  • Epigenetic modulation, specifically reduced histone acetylation, contributes to Aurora A gene regulation by T1.
  • T1 represents a promising candidate for further development as a safe and effective breast cancer therapeutic agent.

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...